Health & Biotech ETFs
Most of these ETFs invest in companies involved in the healthcare and biotechnology industries. These ETFs can also feature healthcare providers, healthcare services, medical devices & equipment, and pharmaceuticals. While some of the category ETFs are focused primarily on growth from Biotech investing, the exposure to the category is ideal for moderate investors that can absorb whatever risk comes with this investing style while knowing there is the consistent revenue exposure to the healthcare industry in a good portion of these ETFs as well.
B
Category Grade
This category ranks #15 out of 65 ETF categories.
A
Strong Buy
Avg. SMART Grade
The average cap-weighted SMART Grade for ETFs in this category is A (Strong Buy).
| Fund Symbol/Name | Last | Open | High | Low | 52-Wk Hi | 52-Wk Lo | Day Chg | YTD Chg | 12-Mo Chg | AUM | Exp. Ratio | SMART Grade |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| XLV SPDR Select Sector Fund - Health Care |
81.34 | 81.47 | 81.84 | 81.21 | 83.41 | 65.96 | -0.24 (-0.29%) |
18.88% | 11.26% | 18.38B | 0.14% |
A Strong Buy |
| IBB iShares Nasdaq Biotechnology Index Fund |
331.40 | 329.49 | 333.17 | 329.48 | 336.72 | 246.71 | +1.46 (0.44%) |
25.08% | 11.14% | 9.72B | 0.47% |
A Strong Buy |
| VHT Vanguard Health Care ETF - DNQ |
151.84 | 152.17 | 152.63 | 151.58 | 154.65 | 120.38 | -0.37 (-0.24%) |
20.57% | 12.67% | 7.08B | 0.10% |
A Strong Buy |
| XBI SPDR Series Trust SPDR S&P Biotech ETF |
84.25 | 83.77 | 84.92 | 83.34 | 85.68 | 53.15 | +0.34 (0.41%) |
42.60% | 23.64% | 4.13B | 0.35% |
A Strong Buy |
| IYH iShares U.S. Healthcare ETF |
171.45 | 171.94 | 172.48 | 171.24 | 174.85 | 137.30 | -0.52 (-0.30%) |
19.62% | 12.05% | 2.08B | 0.44% |
A Strong Buy |
| IXJ iShares Global Healthcare ETF |
112.15 | 112.20 | 112.61 | 111.94 | 113.66 | 92.25 | -0.18 (-0.16%) |
19.35% | 9.56% | 1.61B | 0.47% |
A Strong Buy |
| IHI iShares U.S. Medical Devices ETF |
166.33 | 167.19 | 167.74 | 165.38 | 170.80 | 128.91 | -0.84 (-0.50%) |
25.06% | 14.27% | 1.36B | 0.44% |
A Strong Buy |
| FBT First Trust Amex Biotech Index Fund |
123.48 | 123.00 | 124.00 | 122.51 | 125.32 | 83.69 | +0.49 (0.40%) |
35.87% | 21.20% | 1.14B | 0.55% |
A Strong Buy |
| FXH First Trust Health Care AlphaDEX |
66.56 | 66.75 | 66.92 | 66.47 | 69.24 | 54.51 | -0.33 (-0.49%) |
16.16% | 9.01% | 1.03B | 0.61% |
A Strong Buy |
| FHLC Fidelity MSCI Health Care Index ETF |
39.26 | 39.38 | 39.49 | 39.21 | 40.44 | 31.24 | -0.13 (-0.33%) |
20.22% | 12.24% | 848.42M | 0.08% |
A Strong Buy |
| PJP PowerShares Dynamic Pharmaceuticals |
65.14 | 64.71 | 65.55 | 64.70 | 66.40 | 53.55 | +0.33 (0.51%) |
16.64% | 1.23% | 716.81M | 0.50% |
A Strong Buy |
| BBH VanEck Vectors Biotech ETF |
134.46 | 133.51 | 134.72 | 133.51 | 136.83 | 99.60 | +0.89 (0.67%) |
25.00% | 13.40% | 714.13M | 0.35% |
A Strong Buy |
| RYH Guggenheim S&P 500 Equal Weight Healthcare ETF |
173.61 | 174.17 | 174.59 | 173.37 | 179.90 | 140.98 | -1.00 (-0.57%) |
19.21% | 10.24% | 654.64M | 0.40% |
A Strong Buy |
| IHE iShares U.S. Pharmaceutical ETF |
156.26 | 155.59 | 156.89 | 155.59 | 160.92 | 129.20 | +0.46 (0.30%) |
11.40% | 0.03% | 630.87M | 0.44% |
A Strong Buy |
| IHF iShares U.S. Health Care Providers ETF |
143.42 | 144.37 | 145.12 | 143.41 | 150.75 | 111.40 | -1.66 (-1.14%) |
14.58% | 15.45% | 550.54M | 0.44% |
A Strong Buy |
| PBE PowerShares Dynamic Biotech &Genome |
49.13 | 49.03 | 49.50 | 49.00 | 49.96 | 35.64 | +0.03 (0.06%) |
27.38% | 13.28% | 257.83M | 0.50% |
A Strong Buy |
| PPH VanEck Vectors Pharmaceutical ETF |
57.67 | 57.56 | 57.81 | 57.56 | 60.47 | 50.35 | -0.06 (-0.10%) |
11.33% | -2.85% | 250.35M | 0.35% |
A Strong Buy |
| PSCH PowerShares S&P SmallCap Health Care Portfolio |
89.77 | 89.60 | 89.77 | 89.33 | 90.44 | 63.03 | +0.18 (0.20%) |
22.89% | 18.01% | 228.10M | 0.29% |
A Strong Buy |
| XHE SPDR S&P Health Care Equipment |
62.11 | 62.36 | 62.36 | 61.75 | 63.33 | 46.31 | -0.39 (-0.62%) |
24.91% | 18.93% | 152.78M | 0.35% |
A Strong Buy |
| PTH PowerShares DWA Healthcare Momentum Portfolio |
65.50 | 65.34 | 65.71 | 64.71 | 66.39 | 42.72 | +0.06 (0.09%) |
36.46% | 22.18% | 147.17M | 0.50% |
A Strong Buy |
| SBIO ALPS Medical Breakthroughs ETF |
30.85 | 30.77 | 30.97 | 30.58 | 31.66 | 19.90 | +0.11 (0.36%) |
34.60% | 12.96% | 129.02M | 0.50% |
A Strong Buy |
| CNCR Loncar Cancer Immunotherapy ETF |
26.43 | 25.96 | 26.51 | 25.96 | 27.03 | 19.82 | +0.24 (0.92%) |
24.44% | 1.30% | 43.20M | 0.79% |
A Strong Buy |
| BBP Virtus LifeSci Biotech Products ETF |
40.81 | 40.41 | 40.81 | 40.39 | 41.69 | 27.75 | +0.28 (0.69%) |
24.61% | 18.70% | 40.80M | 0.86% |
A Strong Buy |
| ARKG ARK Genomic Revolution Multi-Sector ETF |
25.58 | 25.80 | 25.80 | 25.41 | 26.10 | 15.85 | -0.18 (-0.70%) |
51.09% | 27.01% | 36.10M | 0.75% |
A Strong Buy |
| BBC Virtus LifeSci Biotech Clinical Trials ETF |
28.35 | 27.89 | 28.69 | 27.89 | 29.14 | 16.33 | +0.15 (0.53%) |
53.99% | 22.99% | 29.54M | 0.85% |
A Strong Buy |
| HCRF iShares Edge MSCI Multifactor Healthcare ETF |
30.15 | 30.27 | 30.27 | 30.13 | 31.12 | 24.23 | -0.14 (-0.46%) |
20.67% | 16.01% | 15.16M | 0.35% |
A Strong Buy |
| XPH SPDR S&P Pharmaceuticals ETF |
42.49 | 42.29 | 42.77 | 42.29 | 46.67 | 36.58 | +0.12 (0.28%) |
8.99% | -9.42% | 429.96M | 0.35% |
B Buy |
| XHS SPDR S&P Health Care Services ETF |
59.02 | 59.19 | 59.19 | 58.83 | 64.96 | 47.50 | -0.29 (-0.49%) |
12.59% | 7.48% | 94.90M | 0.35% |
B Buy |
| JHMH John Hancock Multifactor Healthcare ETF |
30.11 | 30.21 | 30.25 | 30.11 | 33.88 | 24.50 | -0.11 (-0.36%) |
17.24% | 9.69% | 36.32M | 0.50% |
B Buy |
| GNRX VanEck Vectors Generic Drugs ETF |
22.50 | 22.50 | 22.50 | 22.50 | 26.56 | 20.60 | +0.11 (0.49%) |
4.80% | -11.03% | 3.37M | 0.55% |
B Buy |
| BTEC Principal Healthcare Innovators Index ETF |
30.33 | 30.33 | 30.33 | 30.33 | 30.70 | 21.63 | -0.05 (-0.16%) |
31.87% | 14.84% | 7.58M | 0.42% |
NR Not Rated |
| SLIM The Obesity ETF |
28.50 | 28.50 | 28.50 | 28.50 | 29.35 | 21.15 | +0.14 (0.49%) |
27.53% | 12.51% | 2.84M | 0.50% |
NR Not Rated |
| FTXH First Trust Nasdaq Pharmaceuticals ETF |
20.13 | 20.13 | 20.13 | 20.13 | 21.36 | 18.03 | +0.29 (1.46%) |
10.22% | -1.52% | 1.99M | 0.60% |
NR Not Rated |
Get Free Updates
Most Popular Articles
Goldman Sachs Warns Of S&P 500 (SPY) Correction Coming
A Pullback Should Be Expected For The Overextended Dow Jones Industrial Average
Oil Demand Appears To Be Picking Back Up (USO)